Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1

Journal of Leukocyte Biology

Volumn 95, Issue 4, 2014, Pages 651-659

  Jeong, Youngtae ^a   Du, Ronghui ^b   Zhu, Xiaolei ^b   Yin, Shasha ^b   Wang, Jian ^c   Cui, Hengmi ^b   Cao, Wangsen ^b   Lowenstein, Charles J ^d  

^a STANFORD CANCER INSTITUTE   (United States)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cytokine; Inflammation; Inhibitors; Macrophages

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE SILENCING; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CYTOKINE; INFLAMMATION; INHIBITORS; MACROPHAGES;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYTOKINES; DUAL SPECIFICITY PHOSPHATASE 1; HISTONE DEACETYLASES; IMMUNITY, INNATE; INFLAMMATION; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION;

EID: 84899856633     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1013565     Document Type: Article

References (68)

1. Barton, G. M., Medzhitov, R. (2003) Toll-like receptor signaling pathways. Science 300, 1524-1525.
2. Gordon, S. (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930.
3. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145.
4. Chang, L., Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
5. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
6. Dong, C., Davis, R. J., Flavell, R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
7. Keyse, S. M., Emslie, E. A. (1992) Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359, 644-647.
8. Tonks, N. K. (2005) Redox redux: revisiting PTPs and the control of cell signaling. Cell 121, 667-670.
9. Jeffrey, K. L., Camps, M., Rommel, C., Mackay, C. R. (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov. 6, 391-403.
10. Owens, D. M., Keyse, S. M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213.
11. Farooq, A., Zhou, M. M. (2004) Structure and regulation of MAPK phosphatases. Cell. Signal. 16, 769-779.
12. Lang, R., Hammer, M., Mages, J. (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 177, 7497-7504.
13. Alessi, D. R., Smythe, C., Keyse, S. M. (1993) The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8, 2015-2020.
14. Dickinson, R. J., Keyse, S. M. (2006) Diverse physiological functions for dual-specificity MAP kinase phosphatases. J. Cell Sci. 119, 4607-4615.
15. Franklin, C. C., Kraft, A. S. (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272, 16917-16923.
16. Sun, H., Charles, C. H., Lau, L. F., Tonks, N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493.
17. Ichikawa, T., Zhang, J., Chen, K., Liu, Y., Schopfer, F. J., Baker, P. R., Freeman, B. A., Chen, Y. E., Cui, T. (2008) Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1. Endocrinology 149, 4086-4094.
18. Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., Chang, C. H., Liu, Y. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203, 131-140.
19. Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C., Lang, R. (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203, 15-20.
20. Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., Flavell, R. A. (2006) Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103, 2274-2279.
21. Wang, X., Meng, X., Kuhlman, J. R., Nelin, L. D., Nicol, K. K., English, B. K., Liu, Y. (2007) Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria. J. Immunol. 178, 5312-5320.
22. Brondello, J. M., Pouyssegur, J., McKenzie, F. R. (1999) Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514-2517.
23. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., Karin, M. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
24. Cao, W., Bao, C., Padalko, E., Lowenstein, C. J. (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J. Exp. Med. 205, 1491-1503.
25. Beckers, T., Burkhardt, C., Wieland, H., Gimmnich, P., Ciossek, T., Maier, T., Sanders, K. (2007) Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int. J. Cancer 121, 1138-1148.
26. Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., Finn, P. W., Collins, L. S., Tumber, A., Ritchie, J. W., Jensen, P. B., Lichenstein, H. S., Sehested, M. (2008) Determination of the class and isoform selectivity of smallmolecule histone deacetylase inhibitors. Biochem. J. 409, 581-589.
27. Chen, L., Fischle, W., Verdin, E., Greene, W. C. (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653-1657.
28. Chen, L. F., Mu, Y., Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21, 6539-6548.
29. Gu, W., Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
30. Kovacs, J. J., Murphy, P. J., Gaillard, S., Zhao, X., Wu, J. T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., Yao, T. P. (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 18, 601-607.
31. Murphy, P. J., Morishima, Y., Kovacs, J. J., Yao, T. P., Pratt, W. B. (2005) Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J. Biol. Chem. 280, 33792-33799.
32. Yuan, Z. L., Guan, Y. J., Chatterjee, D., Chin, Y. E. (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307, 269-273.
33. Haberland, M., Montgomery, R. L., Olson, E. N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42.
34. Gallinari, P., Di Marco, S., Jones, P., Pallaoro, M., Steinkuhler, C. (2007) HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 17, 195-211.
35. Chakravortty, D., Koide, N., Kato, Y., Sugiyama, T., Mu, M. M., Yoshida, T., Yokochi, T. (2000) The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J. Endotoxin Res. 6, 243-247.
36. Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P., Gilkeson, G. S. (2003) Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539-552.
37. Yu, Z., Zhang, W., Kone, B. C. (2002) Histone deacetylases augment cytokine induction of the iNOS gene. J. Am. Soc. Nephrol. 13, 2009-2017.
38. Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Dona, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P., Fantuzzi, G., Goncharov, I., Kim, S. H., Pomerantz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A., Mascagni, P. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99, 2995-3000.
39. Choi, J. H., Oh, S. W., Kang, M. S., Kwon, H. J., Oh, G. T., Kim, D. Y. (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89-96.
40. Choi, Y., Park, S. K., Kim, H. M., Kang, J. S., Yoon, Y. D., Han, S. B., Han, J. W., Yang, J. S., Han, G. (2008) Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Exp. Mol. Med. 40, 574-581.
41. Reddy, P., Maeda, Y., Hotary, K., Liu, C., Reznikov, L. L., Dinarello, C. A., Ferrara, J. L. (2004) Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc. Natl. Acad. Sci. USA 101, 3921-3926.
42. Li, N., Zhao, D., Kirschbaum, M., Zhang, C., Lin, C. L., Todorov, I., Kandeel, F., Forman, S., Zeng, D. (2008) HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen. Proc. Natl. Acad. Sci. USA 105, 4796-4801.
43. Han, S., Lu, J., Zhang, Y., Cheng, C., Li, L., Han, L., Huang, B. (2007) HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. Immunol. Lett. 108, 143-150.
44. Ito, K., Barnes, P. J., Adcock, I. M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891-6903.
45. Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., Barnes, P. J. (2002) A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA 99, 8921-8926.
46. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., Adcock, I. M. (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J. Exp. Med. 203, 7-13.
47. Greene, W. C., Chen, L. F. (2004) Regulation of NF-κB action by reversible acetylation. Novartis Found. Symp. 259, 208-217.
48. Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G. F., Alcalay, M., Seiser, C., Chiocca, S. (2007) Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27, 4784-4795.
49. Vietor, I., Vadivelu, S. K., Wick, N., Hoffman, R., Cotten, M., Seiser, C., Fialka, I., Wunderlich, W., Haase, A., Korinkova, G., Brosch, G., Huber, L. A. (2002) TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells. EMBO J. 21, 4621-4631.
50. Wilson, A. J., Byun, D. S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., Mariadason, J. M. (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281, 13548-13558.
51. Zupkovitz, G., Tischler, J., Posch, M., Sadzak, I., Ramsauer, K., Egger, G., Grausenburger, R., Schweifer, N., Chiocca, S., Decker, T., Seiser, C. (2006) Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26, 7913-7928.
52. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L., Ayer, D. E. (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347.
53. You, A., Tong, J. K., Grozinger, C. M., Schreiber, S. L. (2001) CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc. Natl. Acad. Sci. USA 98, 1454-1458.
54. Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935.
55. Hassig, C. A., Tong, J. K., Fleischer, T. C., Owa, T., Grable, P. G., Ayer, D. E., Schreiber, S. L. (1998) A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA 95, 3519-3524.
56. Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., Adkins, N. L., Stavreva, D. A., Wiench, M., Georgel, P. T., Schiltz, R. L., Hager, G. L. (2006) HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol. Cell 22, 669-679.
57. Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., Seiser, C. (2002) Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21, 2672-2681.
58. Yang, X. J., Seto, E. (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310-5318.
59. Pediconi, N., Guerrieri, F., Vossio, S., Bruno, T., Belloni, L., Schinzari, V., Scisciani, C., Fanciulli, M., Levrero, M. (2009) hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage. Mol. Cell. Biol. 29, 1989-1998.
60. Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., Hay, R. T. (2003) P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054.
61. Nakajima, T., Fukamizu, A., Takahashi, J., Gage, F. H., Fisher, T., Blenis, J., Montminy, M. R. (1996) The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 86, 465-474.
62. Chawla, S., Hardingham, G. E., Quinn, D. R., Bading, H. (1998) CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science 281, 1505-1509.
63. Ait-Si-Ali, S., Ramirez, S., Barre, F. X., Dkhissi, F., Magnaghi-Jaulin, L., Girault, J. A., Robin, P., Knibiehler, M., Pritchard, L. L., Ducommun, B., Trouche, D., Harel-Bellan, A. (1998) Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396, 184-186.
64. Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H. Y., Wang, J. Y., Nakatani, Y., Kedes, L. (1999) Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413.
65. Zhao, J., Gong, A. Y., Zhou, R., Liu, J., Eischeid, A. N., Chen, X. M. (2012) Downregulation of PCAF by miR-181a/b provides feedback regulation to TNF-α-induced transcription of proinflammatory genes in liver epithelial cells. J. Immunol. 188, 1266-1274.
66. Watson, P. J., Fairall, L., Santos, G. M., Schwabe, J. W. (2012) Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481, 335-340.
67. Grozinger, C. M., Schreiber, S. L. (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840.
68. Zhang, X., Ozawa, Y., Lee, H., Wen, Y. D., Tan, T. H., Wadzinski, B. E., Seto, E. (2005) Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19, 827-839.